Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?-No, never
Keywords: HCC; hepatocellular carcinoma; HCV; hepatitis C virus; LDLT; living-donor liver transplantation; OLT; orthotopic liver transplantation; RFA; radiofrequency ablation; TACE; transarterial chemoembolization; UCSF; University of California San Francisco; UNOS